SCHEMBL14586293

SCHEMBL14586293

CC(C)(C)NC(=O)OC(C)(C)C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.32
POLB P06746 2/20 0.32
APEX1 P27695 1/20 0.32
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8962259 0.86 EPHX1 (0.33) POLBEPHX1
SCHEMBL24019746 0.81 EPHX1 (0.33) POLBEPHX1
SCHEMBL13686206 0.79 TDP1 (0.33)
SCHEMBL14586324 0.77 EPHX1 (0.31) POLBEPHX1
SCHEMBL132657 0.75 DGAT1 (0.42)
SCHEMBL14618042 0.74 EPHX1 (0.36) POLBEPHX1
SCHEMBL13684338 0.74 CA1 (0.38)
Ammonia Solution, Strong SCHEMBL9998482 0.73 DGAT1 (0.41)
SCHEMBL19139139 0.73 EPHX1 (0.34) POLBAPEX1EPHX1
SCHEMBL7365542 0.72 TDP1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173004-B2 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-06 US disclosed